Skip to main content
. 2011 Nov 9;2(11):850–861. doi: 10.18632/oncotarget.347

Figure 4. Outcome of allografted patients according to DNMT3A exon 23 mutations.

Figure 4

DFS (A) and OS (B) in DNMT3A exon 23+ patients (n = 15) and DNMT3A exon 23- patients (n=38) who were allografted in first complete response.